ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
twitter youtube facebook linkedin iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Diagnostic Oncology

PD-L1 in Cytology Specimens

on: December 10, 2019In: Diagnostic Oncology
PD-L1 in Cytology Specimens

By Anjali Saqi, MD, MBA; Deepali Jain, MD, FIAC; Lukas Bubendorf, MD; Keith Kerr, MB, ChB, MRCPath, FRCPath, FRCP(Ed); and Andre Moreira, MD, PhD Posted: December 11, 2019 Lung cancer […] Read more


Global Survey for Pathologists on PD-L1 Testing: Moving Toward Standardization

on: November 11, 2019In: Diagnostic Oncology
Global Survey for Pathologists on PD-L1 Testing: Moving Toward Standardization

By Mari Mino-Kenudson, MD, and Sylvie Lantuejoul, MD, PhD Posted: November 12, 2019 Determination of PD-L1 expression by immunohistochemistry (IHC) has been widely evaluated in clinical trials as a predictive […] Read more

Special Session to Honor Dr. Adi Gazdar

on: August 13, 2019In: Diagnostic Oncology
Special Session to Honor Dr. Adi Gazdar

By Ignacio Wistuba, MD, and John Minna, MD Posted: August 14, 2019 Dr. Adi Gazdar was a scientific pioneer, a groundbreaking pathologist, a loyal friend, and an inspiring mentor. Dr. Gazdar […] Read more

Ki-67 in Pulmonary Neuroendocrine Tumors: Where Do We Stand?

on: May 27, 2019In: Diagnostic Oncology
Ki-67 in Pulmonary Neuroendocrine Tumors: Where Do We Stand?

By Anja C. Roden, MD, and Natasha Rekhtman, MD, PhD Posted: May 27, 2019 Dr. Anja C. Roden Pulmonary neuroendocrine tumors are classified according to the World Health Organization into typical […] Read more

The IASLC Pathology Committee Recommendations for the Use of Diagnostic Immunohistochemistry in Lung Cancer

on: April 04, 2019In: Diagnostic Oncology
The IASLC Pathology Committee Recommendations for the Use of Diagnostic Immunohistochemistry in Lung
            Cancer

By Andre L. Moreira, MD Posted: April 1, 2019 Most of the progress in thoracic oncology is in the treatment of patients with NSCLC. The determination of subtypes of NSCLC, namely […] Read more

Diagnostic Oncology: Reports from the IASLC Pathology Committee

on: February 25, 2019In: Diagnostic Oncology
Diagnostic Oncology: Reports from the IASLC Pathology Committee

By Keith M. Kerr, BSc, MB, ChB, FRCPath, FRCPE Posted: March 1, 2019  There was a time, remembered by us older pathologists, when the image of pathology was that of a […] Read more

The Rising Cost of Lung Cancer Therapies: What Are the Global Implications?

on: February 25, 2019In: Diagnostic Oncology
The Rising Cost of Lung Cancer Therapies: What Are the Global Implications?

By Doreen A. Ezeife, MD, FRCPC; Malcolm Ryan; and Natasha B. Leighl, MD, MMSc, FRCPC, FASCO Posted: March 1, 2019 Dramatic improvements in lung cancer outcomes can be attributed to […] Read more

The Future Is Now: Pathology Is Going Digital

on: December 12, 2018In: Diagnostic Oncology
The Future Is Now: Pathology Is Going Digital

By Sanja Dacic, MD, PhD, and Douglas J. Hartman, MD Posted: December 2018 The pathology community initially showed resistance to digital pathology implementation in routine practice mostly because of pathologists’ […] Read more

12
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2023 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy